Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€9.85

€9.85

-0.510%
-0.05
-0.510%
€31.14

€31.14

 
02.05.24 / Stuttgart Stock Exchange WKN: A12EPL / Symbol: NVRO / Name: Nevro / Stock / Healthcare Equipment & Supplies / Small Cap /
Latest predictions
€21.13
01.12.23
-43.90%
buy
€30.29
17.08.23
-44.03%
buy
€31.99
02.08.23
-46.98%
buy
€37.44
31.05.23
-54.33%
buy
Your prediction

Nevro Corp. Stock

The price for the Nevro Corp. stock decreased slightly today. Compared to yesterday there is a change of -€0.050 (-0.510%).
Currently there is a rather positive sentiment for Nevro Corp. with 4 Buy predictions and 0 Sell predictions.
Based on the current price of 9.85 € the target price of 31 € shows a potential of 214.72% for Nevro Corp. which would more than double the current price.

Pros and Cons of Nevro Corp. in the next few years

Pros
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Nevro Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Nevro Corp. -0.510% -8.796% -15.812% -58.958% -50.253% -92.964% -81.702%
Orasure Tech -1.600% 0.820% -10.545% -20.000% -33.960% -34.921% -42.817%
scPharmaceuticals -1.430% 1.970% -5.479% -56.875% -28.000% -21.887% -
SI-BONE Inc -0.750% 1.527% -6.338% -38.426% -30.000% -54.138% -

Comments

Prediction Buy
Perf. (%) -43.90%
Target price 21.135
Change
Ends at 01.12.24

Nevro Corp. (NYSE: NVRO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $23.00 price target on the stock.
Ratings data for NVRO provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -44.03%
Target price 30.294
Change
Ends at 17.08.24

Nevro Corp. (NYSE: NVRO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $33.00 price target on the stock.
Ratings data for NVRO provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -46.98%
Target price 31.990
Change
Ends at 02.08.24

Nevro Corp. (NYSE: NVRO) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $40.00 to $35.00. They now have an "outperform" rating on the stock.
Ratings data for NVRO provided by MarketBeat
Show more

News

Why Nevro Stock Lagged the Market on Thursday: https://g.foolcdn.com/editorial/images/766494/medical-professional-holding-dollar-sign-paperweight.jpg
Why Nevro Stock Lagged the Market on Thursday

Specialty medical device maker Nevro (NYSE: NVRO) didn't make for an inspiring investment on Thursday. Its stock price dipped marginally following the company's release of its fourth-quarter